Found 36 matching trials
F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence
PHASE3This study evaluates the diagnostic performance and safety of F-18-PSMA-100...
Location
Centre Jean Perrin Clermont-Ferrand
The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI
NAThis study is a multi-center RCT to compare the clinically significant pros...
Location
Prince of Wales Hospital
Diagnostic Accuracy and Performance of 18F-PSMA-1007
N/AWhereas 18F-PSMA-1007 has rapidly established itself as a radiotracer for t...
Location
Inselspital, Universitätsspital Bern
Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer
NARationale: In patients with medullary thyroid cancer (MTC), molecular imagi...
Location
University Medical Centre Groningen
Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA
NAIn 22% of patients with elevated Prostate-specific antigen (PSA) MRI guided...
Location
University Hospital Zurich
18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer
PHASE2Single centre prospective cohort phase II study of 18F-PSMA-1007 PET/CT ima...
Location
University of Alberta
[18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma
EARLY_PHASE1Staging of kidney cancer is primarily achieved by computerized tomography (...
Location
London Health Sciences Centre - Victoria Hospital
PSMA PET for Treatment Response evaLuation of systemIC Therapies in prostAte caNcer (PELICAN)
N/AThis prospective clinical study aims to evaluate the predictive power of PS...
Location
Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient
N/AThe diagnostic tools for detecting patients with early prostate cancer are ...
Location
Tungs'Taichung Metro Harbor Hospital
Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer
PHASE3Less than 50% of patients receiving salvage radiation therapy (SRT) to the ...
Location
Sahlgrenska University Hospital